Uncomplicated Urinary Tract Infection Epidemiology Forecast Report 2021-2030 – ResearchAndMarkets.com | Financial Buzz

Uncomplicated Urinary Tract Infection Epidemiology Forecast Report 2021-2030 – ResearchAndMarkets.com

The “Uncomplicated Urinary Tract Infection – Epidemiology Forecast to 2030” drug pipelines has been added to ResearchAndMarkets.com’s offering.

This ‘Uncomplicated Urinary Tract Infection (uUTI) – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Uncomplicated Urinary Tract Infection epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Epidemiology Perspective

The Uncomplicated Urinary Tract Infection epidemiology division provides insights about the historical and current Uncomplicated Urinary Tract Infection patient pool and forecasted trends for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

In the year 2020, the total occurrence-specific cases of Uncomplicated Urinary Tract Infection was 35.3 million cases in the 7MM which are expected to grow during the study period, i.e., 2018-2030.

Country Wise- Uncomplicated Urinary Tract Infection Epidemiology

Estimates show that the highest cases of Uncomplicated Urinary Tract Infection in the 7MM were in the United States, followed by Japan, Italy, France, the United Kingdom, Germany, and Spain in 2020.

  • In the United States, the total number of occurrence-specific cases of Uncomplicated Urinary Tract Infection was 14.7 million cases in the year 2020 which are expected to grow during the study period, i.e., 2018-2030.
  • In the year 2020, the total occurrence-specific cases of Uncomplicated Urinary Tract Infection were 13.9 million cases in EU-5 which are expected to grow during the study period, i.e., 2018-2030.
  • In Japan, the total number of occurrence-specific cases of Uncomplicated Urinary Tract Infection was 6.7 million cases in the year 2020 which are expected to grow during the study period, i.e., 2018-2030.

Scope of the Report

  • The Uncomplicated Urinary Tract Infection report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns.
  • The Uncomplicated Urinary Tract Infection Report and Model provide an overview of the risk factors and global trends of Uncomplicated Urinary Tract Infection in the seven major markets (7MM: The United States, Germany, France, Italy, Spain, and the United Kingdom, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Uncomplicated Urinary Tract Infection in seven major markets covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
  • The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
  • The report assesses the disease risk and burden and highlights the unmet needs of Uncomplicated Urinary Tract Infection.
  • The report provides the segmentation of the Uncomplicated Urinary Tract Infection epidemiology by total occurrence-specific cases in the 7MM.
  • The report provides the segmentation of the Uncomplicated Urinary Tract Infection epidemiology by total diagnosed cases in the 7MM.
  • The report provides the segmentation of the Uncomplicated Urinary Tract Infection epidemiology by total age-specific cases in the 7MM.
  • The report provides the segmentation of the Uncomplicated Urinary Tract Infection epidemiology by total pathogen-specific cases in the 7MM.
  • The report provides the segmentation of the Uncomplicated Urinary Tract Infection epidemiology by total treated cases (across lines) in the 7MM.

Key Topics Covered:

1. Key Insights

2. Report Introduction

3. Executive Summary of Uncomplicated Urinary Tract Infection (uUTI)

4. Epidemiology Methodology

5. Disease Background and Overview

5.1. Introduction

5.2. Types of UTI

5.3. Signs and Symptoms of Uncomplicated UTI

5.4. Risk Factors and Causes of Uncomplicated UTI

5.5. Pathogenesis of UTI

5.6. Complications of UTI

6. Diagnosis of Uncomplicated UTI

6.1. Diagnostic algorithm

6.2. Clinical Examination

6.3. Lab Tests

6.4. Imaging and other tests

6.4.1. Cystoscopy

6.4.2. Ureteroscopy

6.5. Differential diagnosis

7. Diagnostic Guidelines

7.1. European Association of Urology (EAU) Urological Infections Diagnostic Guidelines

7.2. American Urological Association (AUA) Guidelines

7.3. Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)

8. Epidemiology and Patient Population

8.1. Key Findings

8.2. Epidemiology of Uncomplicated Urinary Tract Infection (uUTI)

8.3. Epidemiology Scenario

8.3.1. Total Occurrence-specific Cases of Uncomplicated Urinary Tract Infection

8.3.2. Total Diagnosed Cases of Uncomplicated Urinary Tract Infection

8.3.3. Total Age-specific Cases of Uncomplicated Urinary Tract Infection

8.3.4. Total Pathogen-specific Cases of Uncomplicated Urinary Tract Infection

8.3.5. Total Treated Cases (across lines) of Uncomplicated Urinary Tract Infection

9. SWOT Analysis

10. Appendix

For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/cpb91j

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!